Kaye Edward M. MD (CIK 1522780) reported 51 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-08-18). Recent activity: Buy STOK (26,250 shares), Sell STOK (11,930 shares), Sell STOK (637 shares), Buy CYTK (151 shares), Sell CYTK (2,933 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | Stoke Therapeutics, Inc. (STOK) | Director | Buy | 26,250 | $0 |
| 2026-08-18 | Stoke Therapeutics, Inc. (STOK) | Director | Sell | 11,930 | $381,846 |
| 2026-08-18 | Stoke Therapeutics, Inc. (STOK) | Director | Sell | 637 | $20,682 |
| 2026-07-16 | CYTOKINETICS INC (CYTK) | Director | Buy | 151 | $12,476 |
| 2026-06-01 | CYTOKINETICS INC (CYTK) | Director | Sell | 2,933 | $223,172 |
| 2026-05-27 | CYTOKINETICS INC (CYTK) | Director | Buy | 2,851 | $0 |
| 2026-04-15 | CYTOKINETICS INC (CYTK) | Director | Buy | 191 | $12,486 |
| 2026-03-17 | Stoke Therapeutics, Inc. (STOK) | Director | Buy | 35,500 | $0 |
| 2026-03-17 | Stoke Therapeutics, Inc. (STOK) | Director | Buy | 26,250 | $0 |
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) | Director | Sell | 6,692 | $0 |
| 2026-01-16 | CYTOKINETICS INC (CYTK) | Director | Buy | 197 | $12,498 |
| 2025-12-10 | Stoke Therapeutics, Inc. (STOK) | Director | Sell | 8,274 | $269,070 |
| 2025-12-10 | Stoke Therapeutics, Inc. (STOK) | Director | Sell | 3,825 | $120,258 |
| 2025-12-10 | Stoke Therapeutics, Inc. (STOK) | Director | Sell | 1,331 | $44,056 |
| 2025-12-05 | Stoke Therapeutics, Inc. (STOK) | Director | Buy | 26,250 | $0 |
| 2025-12-05 | Stoke Therapeutics, Inc. (STOK) | Director | Sell | 5,222 | $160,629 |
| 2025-12-05 | Stoke Therapeutics, Inc. (STOK) | Director | Sell | 1,231 | $38,555 |
| 2025-12-05 | Stoke Therapeutics, Inc. (STOK) | Director | Sell | 6,367 | $199,478 |
| 2025-12-05 | Stoke Therapeutics, Inc. (STOK) | Director | Sell | 1,681 | $52,363 |
| 2025-12-05 | Stoke Therapeutics, Inc. (STOK) | Director | Sell | 500 | $15,925 |
| 2025-12-03 | Stoke Therapeutics, Inc. (STOK) | Director | Buy | 4,317 | $0 |
| 2025-12-03 | Stoke Therapeutics, Inc. (STOK) | Director | Sell | 661 | $19,539 |
| 2025-12-03 | Stoke Therapeutics, Inc. (STOK) | Director | Sell | 405 | $12,207 |
| 2025-12-03 | Stoke Therapeutics, Inc. (STOK) | Director | Sell | 419 | $12,712 |
| 2025-12-03 | Stoke Therapeutics, Inc. (STOK) | Director | Sell | 651 | $20,083 |
Source: SEC Form 4 filings · as of 2026-08-18